About this document

RANBAXY Capital Structure Analysis by Akshay Jadav is a document available to read on EtoBox.

Cipla is an Indian pharmaceutical company founded in 1935. It has grown to become a global generic drug manufacturer with over $1 billion in annual revenue. Cipla has strong market positions in India in key therapeutic areas like asthma, antibiotics, cardiovascular drugs, and anti-AIDS/anticancer drugs. It was an early leader in generic drugs and continues to innovate with new product lines like CFC-free inhalers. Cipla aims to maintain its domestic leadership and further expand globally through its portfol

Author

Akshay Jadav

Language

EN